September 10, 2020 |
Join OPEN Health and Pharmerit – an OPEN Health Company at the World Pharma Pricing Market Access and Evidence Congress from 23 – 25 September 2020, as we present:
ROUNDTABLE: Wednesday, September 23, 13:00
Exploring Digital Therapeutics
Moderated by: Olaf Schoeman, MSc, Director and German Lead
Presentation: Thursday, September 24, 14:30
EUnetHTA Joint Assessments and Implications for the Industry
Rosemary Jose, PhD, Director and Commercial Lead, Strategic Market Access
We welcome you to schedule a meeting with one of our team members Rosemary Jose, Olaf Schoeman, Marja Hensen, Walter Bouwmeester, Andrew Revel, Marie Keetley or Phil Drew to discuss your market access, HEOR and real-world evidence needs.
OPEN Health is a family of expert practices working in partnership to drive positive change in healthcare communications and market access globally. It all started with a vision to create a new, unique entity equipped to be a global leader in HEOR, market access, medical and patient brand communications and digital services. By bringing together the Pharmerit and OPEN VIE teams to create the Evidence and Access practice, we have expanded our global footprint and capabilities in HEOR and market access. This newly integrated team provides world-class knowledge, insight and outputs across the entire spectrum of market access and reimbursement, evidence generation, gathering and evaluation, and population-based health data. Our multidisciplinary teams work across four centers of excellence:
Together, we have grown to over 700 people in 15 offices across 6 different countries including US, UK, The Netherlands, Germany, India and China. What makes us different is our deeply integrated teams working collaboratively to bring the strategic and technical expertise needed to be a solid partner to our sponsors. Combine this with our broad scope of therapeutic expertise to produce results and solutions that are of the highest quality. We pride ourselves on having a highly skilled, diverse, and connected team working across the globe to deliver truly innovative and best-in-class solutions. This has resulted in long-term, flexible partnerships that span many years across multiple brands and therapy areas.
For more information on how we are improving the lives of patients, worldwide, please visit www.openhealthgroup.com
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK
Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. It was great to be joined by many colleagues from all our...
We asked Mina Patel to give us an insight into her role as Global Head of Publications at OPEN Health
Explore more with OPEN Health
Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:Advanced Therapies Commercial: Tuesday, August 25Succeeding with Star Wars...
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !
We are delighted to announce that OPEN Health Medical Communications was named Medical Affairs Agency of the Year at the virtual 2020 Communiqué Awards ceremony on 02 July 2020.
Ditch the Label – it’s just me.
OPEN Health is pleased to announce that Candice Subero has been named Global Marketing Lead, effective June 4, 2020. Candice will oversee strategic communications and marketing efforts across all OPEN...
OPEN Health are proud to support RARE Revolution Magazine who have launched a dedicated RARE youth online platform powering up the voices of the youth rare disease community.